Digital health companies Covera Health and Medmo combined into a single organization on Tuesday to form an end-to-end platform that manages diagnostic imaging.
The platform will reach nearly six million Americans across all 50 states, the companies say, ranging from Fortune 10 and 100 employers, three of the five biggest national health plans and thousands of value-based primary care physicians.
Covera Health uses its artificial intelligence-driven platform to measure diagnostic accuracy at more than 1,100 imaging locations across the U.S. and analyzes completed imaging to flag clinically significant information to route back to clinical decision makers. It has analyzed 21 million patient journeys, generating more than 679,000 insights, its website says.
Meanwhile, Medmo is a care coordination platform for diagnostic imaging, partnering with value-based care organizations, primary care groups, ACOs and health plans. Its focus is on ensuring patients reach the correct imaging centers, complete tests and receive timely follow-up care. The company says it has aided in more than one million cases, showing a 35% decrease in spending and a 30% increase in study completion rates.
Covera Health led Medmo’s $15 million series A funding round, announced in October.
Covera Health CEO Ron Vianu said in a statement that the location a patient receives an imaging test “is not a neutral decision,” adding it can “produce a meaningfully different diagnosis” depending on the site and clinicians.
“That variation was always there,” Vianu said. “Covera built the infrastructure to measure it for the first time and proved that routing patients to the right facility produces meaningfully better outcomes. What we could not do alone was ensure patients reliably reached the right place to begin with, and that the result connected back to the physician and care team who needed to act on it. Medmo solved that. It is the first platform in radiology that closes the loop from the moment a referral is written to the moment a patient is on the right care path.”
Vianu will remain the CEO of Covera Health. Medmo CEO Lucas Takahashi will continue serving as the company’s CEO, but will also take on the role of president for the combined organization.
Takahashi said in a statement that healthcare providers can “lose visibility” when patients leave with imaging orders.
“Medmo closes that gap, ensuring patients reach the right facility, complete their study, and that results get back to the physician who needs to act on them,” Takahashi said. “Joining with Covera means that every step of that journey now carries clinical intelligence. Together, we've built something new for radiology: a platform that delivers quality and coordination as one.”